Cashu | Summary | CARM

HomeWatchlistNewsSignalsPicks

DJI

-0.03%

SPX

+0.03%

IXIC

-0.01%

FTSE

+0.13%

N225

+1.71%

AXJO

+0.73%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

11.92M

Dividend Yield

0.00%

P/E Ratio

-0.24

EPS

-1.46

Revenue

19.63M

Avg. Volume

362.65K

About

What does CARM do?

Carisma Therapeutics, a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focuses on developing immunotherapies for solid tumors, including CAR-M therapies CT-0508 and CT-0525. The company went public in February 2014 and employs 107 people.

Sector

💻 Health Care

IPO

CEO

Employees

46

Headquarters

Massachusetts, USA

Website

http://www.sesenbio.com

Recently from Cashu

Please provide the content you would like summarized, and I'll be happy to help!

about 2 months ago

Carisma Therapeutics: Advancements in Cell Therapy and Future Prospects

about 2 months ago

Carisma Therapeutics: Stock Insights and Future Prospects

Stocks

Health Care

carm

Carisma Therapeutics

NASDAQ: CARM

-0.01 (-2.73%)

0.285

USD

At close at Aug 14, 20:39 UTC